Form4insider filings, from the source

SEC Form 4 · accession 0001104659-18-065497

Organogenesis Holdings Inc. · ORGO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Thompson Dean
Officer — Executive Chairman · Director · 10% Owner
David F Burgstahler
Officer — President & CEO · Director · 10% Owner
Period of report
Oct 30, 2018
Accepted (ET)
Nov 1, 2018 · 6:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001661181

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Class B Ordinary SharesF2,F3,F4,F5,F1—Oct 30, 2018J26,984A——Class A Ordinary Shares26,9844,296,359D

Explanation of responses

Remarks

Exhibit 99.1 Joint Filer Information, incorporated herein by reference.